-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NPI-002 in Cataract
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NPI-002 in Cataract report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.NPI-002 in CataractDrug Details:NPI-002 is under development for the treatment of cataract.Report CoverageThe data...
-
Sector Analysis
Nickel Mining Market Analysis by Reserves, Production, Assets, Demand Drivers and Forecast to 2030
Empower your strategies with our Global Nickel Mining to 2026 report and make more profitable business decisions.Nickel Mining Market Report Overview The nickel production was estimated at 3,372.3kt in 2023. Production in 2023 was supported by the commissioning of the Indonesian NPI, NPI-to-matte conversion capacities, and HPAL projects. The nickel production is expected to garner a CAGR of more than 5% from 2023 to 2030. Based on its purity, nickel ore is classified into Class 1 and Class 2. Class...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Plinabulin in Metastatic Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Plinabulin in Metastatic Breast Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Plinabulin in Metastatic Breast Cancer Drug Details: plinabulin (NPI-2358) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Plinabulin in Merkel Cell Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Plinabulin in Merkel Cell Carcinoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Plinabulin in Merkel Cell Carcinoma Drug Details: plinabulin (NPI-2358) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Plinabulin in Multiple Myeloma (Kahler Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Plinabulin in Multiple Myeloma (Kahler Disease) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Plinabulin in Multiple Myeloma (Kahler Disease) Drug Details:plinabulin (NPI-2358) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Marizomib in Pediatric Diffuse Intrinsic Pontine Glioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Marizomib in Pediatric Diffuse Intrinsic Pontine Glioma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Marizomib in Pediatric Diffuse Intrinsic Pontine Glioma Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Marizomib in Glioblastoma Multiforme (GBM)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Marizomib in Glioblastoma Multiforme (GBM) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Marizomib in Glioblastoma Multiforme (GBM) Drug Details: Marizomib (NPI-0052) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Marizomib in Malignant Glioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Marizomib in Malignant Glioma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Marizomib in Malignant Glioma Drug Details: Marizomib (NPI-0052) is under development for...
-
Product Insights
Ophthalmic Diagnostic Equipment Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Ophthalmic Diagnostic Equipment Pipeline Market Report Overview Ophthalmic diagnostic equipment helps in examining the eye for study purposes as well as for the treatment of different pathologies of the eye. The Ophthalmic Diagnostic Equipment pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the...